Table 1.

Overview of study patients

	Pre-transplantation characteristics								Post-transplantation characteristics
	Age (years)	Sex	Disease duration (years)	RF-IgM (IU/ml)	ACPA-IgG (AU/ml)	CRP (mg/l)	ESR (mm/hour)	DAS44	Lowest DAS44	DMARD-free days	DAS44 at start or DMARDs
Patient 1	51	Female	7	575	94	12	40	5.89	0.89	423	2.62
Patient 2	43	Male	11	1,096	215	57	126	5.13	1.95	163	4.10
Patient 3	42	Female	15	500	401	50	61	4.58	1.94	738	3.40
Patient 4	35	Female	9	61	577	2	49	4.77	3.52	60	5.16
Patient 5	45	Female	12	1,656	1,014	192	113	5.49	1.82	67	3.72
Patient 6	42	Female	20	1,796	1,584	59	64	7.24	3.80	184	4.95

ESR, erythrocyte sedimentation rate; DAS₄₄, Disease Activity Score of 44 joints; DMARD, disease-modifying antirheumatic drug.